IXA assists researchers in creating value from their knowledge and expertise. We help them to cooperate with third parties, assist them in intellectual property management, offer support in starting new ventures and activities, and provide legal support. IXA also manages financial instruments to aid further development of their ideas and ventures.
In addition the IXA UvA and IXA HvA teams supports UvA, HvA, AHK and KNAW HuC staff seeking for research funding or when applying for research grants with the expertise of the Grant Support Team. The deployment of their expertise increases the chance of success.
IXA assists external parties such as companies, governments and interest groups in navigating the research landscape to find a solution or spot an opportunity. IXA provides the gateway to the research expertise and facilities of the Amsterdam universities – as an expertise centre, helpdesk and liaison, all in one. All to the benefit of the entrepreneurial climate in the Amsterdam metropolitan area.
Next to offering a wide range of services of our business developers and advisors, we also closely cooperate with other parties in the Amsterdam innovation landscape. When opportunities arise, IXA takes the lead in developing programs and activities to further stimulate economic activity and entrepreneurship in research and education.
IXA can operate and assist in various roles. We can actively participate in the negotiations on research collaborations or licensing agreements with industry or other public research organisations. Setting up consortium agreements and contracts dealing with access to or transfer of intellectual property rights is another important service, as is drafting patent applications and advising on the best approach towards protecting intellectual property. We can assist in finding and securing subsidies and other forms of financial support. And foremost, we can help you to identify the best valorisation strategy for your particular idea, discovery, invention, technology, material or insight.
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News